Achyut Healthcare Limited (ACHYUT.BO)

INR 3.25

(4.84%)

EBITDA Summary of Achyut Healthcare Limited

  • Achyut Healthcare Limited's latest annual EBITDA in 2023 was 524 Thousand INR , up 109.26% from previous year.
  • Achyut Healthcare Limited's latest quarterly EBITDA in 2024 Q2 was 4.83 Million INR , down 0.0% from previous quarter.
  • Achyut Healthcare Limited reported an annual EBITDA of -2.59 Million INR in 2022, down -610.44% from previous year.
  • Achyut Healthcare Limited reported an annual EBITDA of -334 Thousand INR in 2021, down -401.57% from previous year.
  • Achyut Healthcare Limited reported a quarterly EBITDA of 171.5 Thousand INR for 2023 Q1, up 105.93% from previous quarter.
  • Achyut Healthcare Limited reported a quarterly EBITDA of -91 Thousand INR for 2023 Q4, down -100.0% from previous quarter.

Annual EBITDA Chart of Achyut Healthcare Limited (2023 - 2018)

Historical Annual EBITDA of Achyut Healthcare Limited (2023 - 2018)

Year EBITDA EBITDA Growth
2023 524 Thousand INR 109.26%
2022 -2.59 Million INR -610.44%
2021 -334 Thousand INR -401.57%
2020 104 Thousand INR 49.41%
2019 85 Thousand INR -37.96%
2018 2000.00 INR 0.0%

Peer EBITDA Comparison of Achyut Healthcare Limited

Name EBITDA EBITDA Difference
Alembic Pharmaceuticals Limited 9.61 Billion INR 99.995%
Aurobindo Pharma Limited 61.78 Billion INR 99.999%
Glenmark Life Sciences Limited 6.86 Billion INR 99.992%
Granules India Limited 8.6 Billion INR 99.994%
Indoco Remedies Limited 2.64 Billion INR 99.98%
Ajanta Pharma Limited 12.56 Billion INR 99.996%
Alkem Laboratories Limited 24.19 Billion INR 99.998%
Alpa Laboratories Limited 86.12 Million INR 99.392%
Brooks Laboratories Limited 41.72 Million INR 98.744%
AstraZeneca Pharma India Limited 2.35 Billion INR 99.978%
Bajaj HealthCare Limited 444.51 Million INR 99.882%
Bliss GVS Pharma Limited 1.47 Billion INR 99.965%
Dr. Reddy's Laboratories Limited 88.27 Billion INR 99.999%
Eris Lifesciences Limited 6.98 Billion INR 99.992%
FDC Limited 4.4 Billion INR 99.988%
Glenmark Pharmaceuticals Limited 11.34 Billion INR 99.995%
Gufic Biosciences Limited 1.48 Billion INR 99.965%
Ind-Swift Laboratories Limited 6.86 Billion INR 99.992%
Ipca Laboratories Limited 13.29 Billion INR 99.996%
Jagsonpal Pharmaceuticals Limited 323.46 Million INR 99.838%
Krebs Biochemicals & Industries Limited -82.72 Million INR 100.633%
Lasa Supergenerics Limited -65.08 Million INR 100.805%
Laurus Labs Limited 8 Billion INR 99.993%
Lupin Limited 36.96 Billion INR 99.999%
Mankind Pharma Limited 28.09 Billion INR 99.998%
Medicamen Biotech Limited 245.66 Million INR 99.787%
Medico Remedies Limited 150.37 Million INR 99.652%
Megasoft Limited 284.73 Million INR 99.816%
NATCO Pharma Limited 18.79 Billion INR 99.997%
Piramal Pharma Limited 13.05 Billion INR 99.996%
RPG Life Sciences Limited 1.28 Billion INR 99.959%
Sigachi Industries Limited 883.39 Million INR 99.941%
Sun Pharmaceutical Industries Limited 138.36 Billion INR 100.0%
Suven Pharmaceuticals Limited 4.67 Billion INR 99.989%
Syncom Formulations (India) Limited 430.27 Million INR 99.878%
Unichem Laboratories Limited 742.35 Million INR 99.929%
Wanbury Limited 985.49 Million INR 99.947%
Windlas Biotech Limited 781.72 Million INR 99.933%
ZIM Laboratories Limited 462.09 Million INR 99.887%
Zydus Lifesciences Limited 56.22 Billion INR 99.999%
Sun Pharma Advanced Research Company Limited -3.73 Billion INR 100.014%
Divi's Laboratories Limited 25.43 Billion INR 99.998%
Hester Biosciences Limited 539.47 Million INR 99.903%
Procter & Gamble Health Limited 3.01 Billion INR 99.983%
Amrutanjan Health Care Limited 682.53 Million INR 99.923%
Bal Pharma Limited 345.59 Million INR 99.848%
Strides Pharma Science Limited 3.76 Billion INR 99.986%
Venus Remedies Limited 711.8 Million INR 99.926%
Aarti Pharmalabs Limited 3.9 Billion INR 99.987%
Nectar Lifesciences Limited 1.56 Billion INR 99.966%
Shilpa Medicare Limited 2.58 Billion INR 99.98%
Aarti Drugs Limited 3.24 Billion INR 99.984%
IOL Chemicals and Pharmaceuticals Limited 2.6 Billion INR 99.98%
Suven Life Sciences Limited -992.78 Million INR 100.053%
Ind-Swift Limited 1.06 Billion INR 99.951%
Valiant Laboratories Limited 12.73 Million INR 95.887%
J. B. Chemicals & Pharmaceuticals Limited 9.33 Billion INR 99.994%
Solara Active Pharma Sciences Limited -2.82 Billion INR 100.019%
Themis Medicare Limited 562.6 Million INR 99.907%
Hikal Limited 2.69 Billion INR 99.981%
Torrent Pharmaceuticals Limited 35 Billion INR 99.999%
Sequent Scientific Limited 549.8 Million INR 99.905%
Novartis India Limited 1.26 Billion INR 99.959%
Wockhardt Limited 1.08 Billion INR 99.951%
Jubilant Pharmova Limited 8 Billion INR 99.993%
Biofil Chemicals and Pharmaceuticals Limited 13.06 Million INR 95.988%
Neuland Laboratories Limited 4.74 Billion INR 99.989%
Morepen Laboratories Limited 1.72 Billion INR 99.97%
Kilitch Drugs (India) Limited 287.42 Million INR 99.818%
Mangalam Drugs & Organics Limited 174.94 Million INR 99.7%